Friday 6 November 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024.

Revenue: +29.2%
EPS: +178.4%
Free cash flow: +38.9%
Total debt: +1,765.6%

Quarter to September 2026, against a year earlier

253.57 12.11 +5.02%

Follow MRNA

Alert me

Market cap: $96.4B
P/E: 0.0×
Fwd P/E: −26.1×
Dividend yield: —
F-score: 3/9
Altman Z: 2.46
Beneish M: −3.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 6 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	1	1	4
ROE Full definition →		(28.87%)	(36.56%)	(39.00%)	(34.50%)
ROA Full definition →		(21.31%)	(26.41%)	(27.43%)	(21.79%)
ROIC Full definition →		(55.51%)	(76.00%)	(93.47%)	(109.92%)
Return on Tangible Assets Full definition →		(42.18%)	(58.49%)	(59.01%)	(37.94%)
Average Days of Receivables Full definition →		34.55	11.65	2.79	197.61
Free Cash Flow per Share Full definition →		(5.33)	(4.06)	(3.13)	(5.10)
Free Cash Flow Full definition →		(2,075.00)	(1,603.00)	(1,244.00)	(2,044.00)
Capital Expenditures Full definition →		(202.00)	(137.00)	(171.00)	(259.00)
Other line items
Cash ROIC Full definition →		(13.78%)	(12.13%)	(9.96%)	(17.02%)
Accounts Receivable Turnover Full definition →		7.17	29.87	84.08	2.09
Accounts Payable Turnover Full definition →		2.40	8.96	9.98	6.91
Inventory Turnover Full definition →		6.43	12.65	6.57	5.64
Average Days of Payables Full definition →		133.30	33.91	35.71	52.00
Days of Inventory on Hand Full definition →		64.34	30.75	59.87	62.84
Tax Rate Full definition →		0.02	0.02	0.02	0.02
Research and Development Expense of Revenue Full definition →		161.11%	131.46%	129.08%	105.27%
Selling, General and Administrative Expense of Revenue Full definition →		52.37%	44.00%	43.31%	0.00%
Share Based Compensation of Revenue Full definition →		24.85%	21.21%	20.74%	18.38%
Operating CF/Net income Full definition →		0.66	0.46	0.34	0.64
Depreciation/Fixed assets Full definition →		0.07	0.08	0.09	0.10
Capex/Depreciation Full definition →		(1.36)	(0.78)	(0.90)	(1.23)
Revenue per Share Full definition →		5.00	5.63	5.60	6.30
Operating CF per Share Full definition →		(4.81)	(3.71)	(2.70)	(4.45)
Capex per Share Full definition →		(0.52)	(0.35)	(0.43)	(0.65)
Capex to Sales Full definition →		0.10	0.06	0.08	0.10

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly